Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 3 , Pages 433-446, June 2008

Single gene mutations causing SGA

Department of Paediatrics, J6-S, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands

The growth hormone–insulin-like growth factor-I (GH–IGF-I) axis plays a key role in intra-uterine growth and development. This review will describe the consequences of genetic defects in various components of the GH–IGF-I axis on intra-uterine growth and development. Animal knockout experiments have provided evidence for the GH-independent secretion of IGF-I and its effect in utero. Reports of patients with a deletion or mutation of the IGF-I and IGF1R genes have provided insight into the role of intra-uterine IGF-I in the human. Homozygous defects of the IGF-I gene have dramatic effects on intra-uterine growth and development, whereas heterozygous defects of the IGF1R gene have a more variable clinical presentation. The phenotype in relation to the genotype of the different disorders will be reviewed in this chapter.

Key words: IGF-I, growth hormone, insulin, receptor, mutation, IUGR, development

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(08)00029-8

doi:10.1016/j.beem.2008.02.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 3 , Pages 433-446, June 2008